Related Experiment Video
Updated: Aug 8, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
Published on: January 7, 2019
Distinct signaling functions for Shc isoforms in the heart
Maria Obreztchikova1, Hasnae Elouardighi, Mengfei Ho
1Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
This study reveals how thrombin signaling impacts cardiac fibroblasts and cardiomyocytes, highlighting the role of Shc proteins in ventricular remodeling and heart failure development. It identifies p66Shc as a potential mediator of cardiomyocyte apoptosis.
Area of Science:
- Cardiovascular Biology
- Cell Signaling
- Molecular Medicine
Background:
- Thrombin activates protease-activated receptor-1 (PAR-1), influencing cardiomyocyte growth and cardiac fibroblast extracellular matrix remodeling.
- Ventricular remodeling is a key process in the transition to heart failure.
Purpose of the Study:
- To investigate the role of Shc proteins in PAR-1-dependent signaling pathways.
- To understand the mechanisms underlying thrombin-induced ventricular remodeling.
Main Methods:
- Examined Shc protein phosphorylation in cardiac fibroblasts and cardiomyocytes.
- Utilized pertussis toxin and specific agonists to probe signaling pathways.
- Assessed p66Shc protein expression in neonatal and adult cardiomyocytes.
Main Results:
- Thrombin induced Shc phosphorylation via epidermal growth factor receptor (EGFR) transactivation in cardiac fibroblasts, involving MEK for p66Shc-Ser(36) phosphorylation.
- Beta(2)-adrenergic receptors activated ERK via a distinct EGFR transactivation pathway in fibroblasts, independent of Shc.
- Thrombin triggered MEK-dependent p66Shc-Ser(36) phosphorylation in cardiomyocytes, but not via EGFR transactivation.
- p66Shc expression was present in neonatal but induced in adult cardiomyocytes by a Galpha(q) agonist, requiring protein kinase C and MEK activity.
Conclusions:
- Identified novel regulation of Shc isoforms in receptor-dependent pathways contributing to cardiac hypertrophy and heart failure.
- p66Shc is a potential mediator of cardiomyocyte apoptosis and heart failure, induced by Galpha(q) agonists and activated by PAR-1 signaling.
More Related Videos
13:13High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
06:51Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart
Published on: August 10, 2018
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...